Filing Details
- Accession Number:
- 0001209191-15-014941
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-17 20:46:12
- Reporting Period:
- 2015-02-13
- Filing Date:
- 2015-02-17
- Accepted Time:
- 2015-02-17 20:46:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1107332 | Dendreon Corp | DNDNQ | Pharmaceutical Preparations (2834) | 223203193 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1596060 | Seth Andrew Sandler | 1301 2Nd Ave Seattle WA 98101 | Evp, Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-02-13 | 7,791 | $0.09 | 313,839 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-02-13 | 105,925 | $0.09 | 207,914 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Open market sale